Northern RNA, Inc.


Northern RNA is a leading Contract Development and Manufacturing Organization (CDMO) specializing in the manufacturing and production of nucleic acid products used in applications including mRNA vaccines, DNA vaccines, mRNA therapies, gene editing, and gene therapies. Founded in 2020, the company aims to provide secure, clinical-to-commercial scale, GMP-grade manufacturing for global clients, supporting innovative therapies and advancing Canada's biomanufacturing sector.

Industries

biotechnology
manufacturing
medical

Nr. of Employees

small (1-50)

Northern RNA, Inc.


Products

Codon- and UTR-optimized linear plasmid DNA (ready-to-order)

RNase-free, codon- and UTR-optimized linear plasmid DNA produced using proprietary purification methods with endotoxin clearance; available in research, RSM, and GMP grades for preclinical and clinical use.

Capped and modified mRNA (ready-to-order)

High-quality capped and modified mRNA produced with methods to reduce double-stranded RNA and other impurities; available in research and GMP grades and suitable for R&D, GLP, and clinical studies.

Co-transcriptional cap analog reagent

Co-transcriptional cap analog reagents for use during in vitro transcription to generate capped mRNA with improved translational efficiency and protection from exonuclease degradation; available in multiple pack sizes and in research or GMP grades.


Services

Biomanufacturing

Platform-scale biomanufacturing services for research and GMP applications including process scale-up, documentation support, and QA oversight.

Plasmid DNA Production

Production of research, RSM, and GMP-grade linear and supercoiled plasmid DNA with support for complex constructs and fill/finish options.

mRNA Production

Manufacture of research, RSM, and GMP-grade mRNA (short and long constructs) with double-stranded RNA clearance, documentation, and QA processes for clinical readiness.

Microbial Cell Banking

Creation of parental, research, master, and working cell banks under ISO-classified conditions with validated release assays and QA oversight.

Formulation and LNP Services

End-to-end formulation development and manufacturing support for LNP-encapsulated nucleic acids, including characterization, process transfer, and clinical-scale production readiness.

Chemical Manufacturing

Chemical synthesis and purification for cap analogs, lipids, and custom reagents with kg-scale production capability and proprietary purification methods.

View All Services

Expertise Areas

  • mRNA drug substance and drug product manufacturing
  • Plasmid DNA production and construct optimization
  • LNP formulation and lipid manufacturing
  • Chemical synthesis for biologics reagents (cap analogs, lipids, oligonucleotides)
  • Show More (5)

Key Technologies

  • Lipid nanoparticle (LNP) formulation
  • Microfluidic rapid mixing
  • Tangential flow filtration (TFF)
  • Lyophilization
  • Show More (9)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.